Adipotide Dosage Chart & Schedule
Adipotide (FTPP) is an experimental targeting peptidomimetic aimed at the vasculature supporting white adipose tissue. In preclinical studies it induced fat loss by triggering apoptosis of the blood vessels feeding fat. It is preclinical/research-only, with notable renal toxicity signals in animal work.
Adipotide has no established human dosing. In rhesus primate studies it was given at about 0.43 mg/kg/day subcutaneously for roughly 4 weeks, and reversible kidney toxicity was observed. It is preclinical/research-only.
Figures describe how Adipotide is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.
Dosage protocols
Commonly referenced research tiers. Start conservative; every compound and study context differs.
- Frequency
- Once daily (in studies)
- Weekly total
- Not established for humans
- Cycle
- ~4 weeks (primate studies)
Reversible renal toxicity was reported at this dose in primates, which is a central safety concern for this compound.
Targets fat's blood supply, with a kidney signal
- A homing motif binds prohibitin/annexin-A2 on white-fat blood vessels and delivers a pro-apoptotic KLAKLAK domain, pruning the vasculature feeding adipose tissue.
- Rhesus primate studies reported reversible kidney effects at the studied dose, underscoring that this is a research compound, not a validated human therapeutic.
Ready to run this protocol?
Dosing is only as good as the vial. Research-grade peptides are third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.
Weekly schedule
A typical week on the primate study reference protocol (Once daily (in studies)).
Dosing day Off
From vial to injection in 6 steps
Wipe both vial tops
Swab the peptide vial and the bacteriostatic-water vial with fresh alcohol and let them dry.
Draw the water
Pull the planned amount of bacteriostatic water (2 mL) into the syringe.
Add it slowly
Run the water down the inside wall of the vial — don't blast the powder. Swirl gently; never shake.
Let it dissolve
Wait until the solution is fully clear, then refrigerate the vial.
Draw your dose
Pull the calculated units on a U-100 insulin syringe.
Store between uses
Keep the reconstituted vial refrigerated and use within its stable window.
Handling & storage
- A 10 mg vial reconstituted with 2 mL of bacteriostatic water gives 5 mg/mL (1 unit on a U-100 syringe is about 50 mcg).
- There is no human dose to convert to; the only reference amounts are weight-based primate protocols.
- Reported animal renal toxicity is a serious limitation of this compound.
- Preclinical/research-only; not approved or validated for human use.
Adipotide dosing FAQ
Is there a human dose for adipotide?
No. There is no established human dosing. The only reference is roughly 0.43 mg/kg/day subcutaneously used in rhesus primate studies for about 4 weeks.
What are the safety concerns?
Primate studies reported reversible kidney (renal) toxicity at the studied dose, which is the main reason adipotide has not advanced as a human weight-loss agent.
How would a vial be reconstituted?
As an illustration only, a 10 mg vial with 2 mL of bacteriostatic water yields 5 mg/mL. This does not imply a safe human dose exists.
Has adipotide been approved for fat loss?
No. It is preclinical/research-only and has not been validated for human use.
Sources
Categories: GLP-1 & Metabolic · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.